David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
VSE Corp
VSEC
$6.11B
| $1M | ﹤0.01% |
20,685
-2,433
| -11% | -$125K |
|
2527
Pacira BioSciences
PCRX
$1.02B
| $1M | ﹤0.01% |
21,900
+12,049
| +122% | +$478K |
|
2528
Natural Health Trends
NHTC
$15.1M
| $997K | ﹤0.01% |
65,640
+40,258
| +159% | +$759K |
|
2529
Stepan Co
SCL
$1.41B
| $997K | ﹤0.01% |
12,628
-2,164
| -15% | -$178K |
|
|
LADR
2530
Ladder Capital
LADR
$1.26B
| $994K | ﹤0.01% |
72,901
-210,651
| -74% | -$2.88M |
|
2531
CALL
Truist Financial
TFC
$61.4B
| $994K | ﹤0.01% |
20,000
| – | – |
|
2532
PUT
Regions Financial
RF
$26.1B
| $987K | ﹤0.01% |
57,100
| – | – |
|
2533
Novanta
NOVT
$5.28B
| $986K | ﹤0.01% |
19,722
-48,344
| -71% | -$2.36M |
|
|
SIGM
2534
DELISTED
Sigma Designs Inc
SIGM
| $984K | ﹤0.01% |
141,627
+14,998
| +12% | +$94K |
|
2535
UBS Group
UBS
$166B
| $983K | ﹤0.01% |
+53,478
| New | +$929K |
|
2536
Steris
STE
$23.1B
| $981K | ﹤0.01% |
11,217
-12,824
| -53% | -$1.14M |
|
|
CRC
2537
DELISTED
California Resources Corporation
CRC
| $981K | ﹤0.01% |
+50,464
| New | +$708K |
|
|
MOMO
2538
CALL
Hello Group
MOMO
$853M
| $979K | ﹤0.01% |
+40,000
| New | +$1.15M |
|
2539
CALL
Alaska Air
ALK
$4.84B
| $978K | ﹤0.01% |
13,300
+3,300
| +33% | +$235K |
|
|
ONC
2540
PUT
BeOne Medicines Ltd
ONC
$42.6B
| $977K | ﹤0.01% |
+10,000
| New | +$915K |
|
2541
DMC Global
BOOM
$141M
| $976K | ﹤0.01% |
38,969
-35,209
| -47% | -$723K |
|
2542
CALL
Visteon
VC
$2.77B
| $976K | ﹤0.01% |
7,800
| – | – |
|
|
GHL
2543
PUT
DELISTED
Greenhill & Co., Inc.
GHL
| $975K | ﹤0.01% |
50,000
| – | – |
|
2544
Lindsay Corp
LNN
$1.16B
| $972K | ﹤0.01% |
11,025
-14,276
| -56% | -$1.3M |
|
|
WOW
2545
DELISTED
WideOpenWest
WOW
| $971K | ﹤0.01% |
91,849
-74,424
| -45% | -$875K |
|
|
BBG
2546
DELISTED
Bill Barrett Corp
BBG
| $971K | ﹤0.01% |
189,322
-91,621
| -33% | -$469K |
|
|
IMMU
2547
PUT
DELISTED
Immunomedics Inc
IMMU
| $970K | ﹤0.01% |
+60,000
| New | +$708K |
|
2548
Resources Connection
RGP
$147M
| $969K | ﹤0.01% |
62,688
-32,362
| -34% | -$500K |
|
|
SVM
2549
Silvercorp Metals
SVM
$2.84B
| $969K | ﹤0.01% |
371,644
+66,764
| +22% | +$170K |
|
2550
CALL
New Oriental
EDU
$9.08B
| $968K | ﹤0.01% |
10,300
| – | – |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.